{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T06:56:06Z","timestamp":1773384966159,"version":"3.50.1"},"reference-count":76,"publisher":"EDITORA SCIENTIFIC","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Bras. Psiquiatr."],"DOI":"10.1590\/1516-4446-2013-1341","type":"journal-article","created":{"date-parts":[[2014,10,4]],"date-time":"2014-10-04T19:08:37Z","timestamp":1412449717000},"page":"03-12","source":"Crossref","is-referenced-by-count":40,"title":["Design and rationale of a 16-week adjunctive randomized placebo-controlled trial of mitochondrial agents for the treatment of bipolar depression"],"prefix":"10.47626","volume":"37","author":[{"given":"Olivia M.","family":"Dean","sequence":"first","affiliation":[{"name":"Deakin University, Australia; University of Melbourne, Australia; University of Melbourne, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alyna","family":"Turner","sequence":"additional","affiliation":[{"name":"Deakin University, Australia; University of Newcastle, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gin S.","family":"Malhi","sequence":"additional","affiliation":[{"name":"University of Sydney, Australia; CADE Clinic, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chee","family":"Ng","sequence":"additional","affiliation":[{"name":"Department of Psychiatry University of Melbourne, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sue M.","family":"Cotton","sequence":"additional","affiliation":[{"name":"Orygen Youth Health Research Centre, Australia; University of Melbourne, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seetal","family":"Dodd","sequence":"additional","affiliation":[{"name":"Deakin University, Australia; University of Melbourne, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerome","family":"Sarris","sequence":"additional","affiliation":[{"name":"University of Melbourne, Australia; Swinburne University of Technology, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuval","family":"Samuni","sequence":"additional","affiliation":[{"name":"Deakin University, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Tanious","sequence":"additional","affiliation":[{"name":"University of Sydney, Australia; CADE Clinic, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathan","family":"Dowling","sequence":"additional","affiliation":[{"name":"Department of Psychiatry University of Melbourne, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Astrid","family":"Waterdrinker","sequence":"additional","affiliation":[{"name":"Deakin University, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deidre","family":"Smith","sequence":"additional","affiliation":[{"name":"Department of Psychiatry University of Melbourne, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Berk","sequence":"additional","affiliation":[{"name":"Deakin University, Australia; University of Melbourne, Australia; University of Melbourne, Australia; Orygen Youth Health Research Centre, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"27448","published-online":{"date-parts":[[2014,10,7]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1001\/archpsyc.59.6.530","article-title":"The long-term natural history of the weekly symptomatic status of bipolar I disorder","volume":"59","author":"Judd LL","year":"2002","journal-title":"Arch Gen Psychiatry"},{"key":"ref2","first-page":"53","article-title":"The risk of suicide in patients with bipolar disorders","volume":"60","author":"Simpson SG","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/j.1399-5618.2007.00507.x","article-title":"Agomelatine adjunctive therapy for acute bipolar depression: preliminary open data","volume":"9","author":"Calabrese JR","year":"2007","journal-title":"Bipolar Disord"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jad.2006.11.025","article-title":"Open-label aripiprazole in the treatment of acute bipolar depression: a prospective pilot trial","volume":"101","author":"McElroy SL","year":"2007","journal-title":"J Affect Disord"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1056\/NEJMoa064135","article-title":"Effectiveness of adjunctive antidepressant treatment for bipolar depression","volume":"356","author":"Sachs GS","year":"2007","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1177\/0004867412449303","article-title":"Mitochondrial modulators for bipolar disorder: a pathophysiologically informed paradigm for new drug development","volume":"47","author":"Nierenberg AA","year":"2013","journal-title":"Aust N Z J Psychiatry"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.tips.2013.01.001","article-title":"The promise of N-acetylcysteine in neuropsychiatry","volume":"34","author":"Berk M","year":"2013","journal-title":"Trends Pharmacol Sci"},{"key":"ref8","first-page":"CD004426","article-title":"Treatment for mitochondrial disorders","volume":"25","author":"Chinnery PF","year":"2006","journal-title":"Cochrane Database Sys Rev"},{"key":"ref9","first-page":"136","article-title":"The underlying neurobiology of bipolar disorder","volume":"2","author":"Manji HK","year":"2003","journal-title":"World Psychiatry"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1017\/S1092852900015303","article-title":"Psychiatric comorbidity in 36 adults with mitochondrial cytopathies","volume":"12","author":"Fattal O","year":"2007","journal-title":"CNS Spectr"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1399-5618.2008.00649.x","article-title":"Resting energy expenditure in manic episode","volume":"11","author":"Caliyurt O","year":"2009","journal-title":"Bipolar Disord"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1001\/archpsyc.1985.01790280019002","article-title":"Cerebral metabolic rates for glucose in mood disorders. Studies with positron emission tomography and fluorodeoxyglucose F 18","volume":"42","author":"Baxter LR","year":"1985","journal-title":"Arch Gen Psychiatry"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1034\/j.1399-5618.2002.01180.x","article-title":"31P-MRS study of acetyl-L-carnitine treatment in geriatric depression: preliminary results","volume":"4","author":"Pettegrew JW","year":"2002","journal-title":"Bipolar Disord"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0165-0327(92)90099-R","article-title":"Brain phosphorous metabolism in depressive disorders detected by phosphorus-31 magnetic resonance spectroscopy","volume":"26","author":"Kato T","year":"1992","journal-title":"J Affect Disord"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0165-0327(94)90116-3","article-title":"Reduction of brain phosphocreatine in bipolar II disorder detected by phosphorus-31 magnetic resonance spectroscopy","volume":"31","author":"Kato T","year":"1994","journal-title":"J Affect Disord"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1017\/S003329170003347X","article-title":"Lateralized abnormality of high energy phosphate metabolism in the frontal lobes of patients with bipolar disorder detected by phase-encoded 31P-MRS","volume":"25","author":"Kato T","year":"1995","journal-title":"Psychol Med"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1017\/S0033291799001439","article-title":"Altered brain energy metabolism in lithium-resistant bipolar disorder detected by photic stimulated 31P-MR spectroscopy","volume":"30","author":"Murashita J","year":"2000","journal-title":"Psychol Med"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0006-3223(97)00012-7","article-title":"Increased levels of a mitochondrial DNA deletion in the brain of patients with bipolar disorder","volume":"42","author":"Kato T","year":"1997","journal-title":"Biol Psychiatry"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00702-006-0581-8","article-title":"Quantification of total mitochondrial DNA and mitochondrial common deletion in the frontal cortex of patients with schizophrenia and bipolar disorder","volume":"114","author":"Sabunciyan S","year":"2007","journal-title":"J Neural Transm"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.neulet.2008.05.009","article-title":"Quantitative analysis of the 4977-bp common deletion of mitochondrial DNA in postmortem frontal cortex from patients with bipolar disorder and schizophrenia","volume":"439","author":"Fuke S","year":"2008","journal-title":"Neurosci Lett"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jad.2011.06.005","article-title":"The efficacy of N-acetylcysteine as an adjunctive treatment in bipolar depression: an open label trial","volume":"135","author":"Berk M","year":"2011","journal-title":"J Affect Disord"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1741-7015-10-91","article-title":"Maintenance N-acetyl cysteine treatment for bipolar disorder: a double-blind randomized placebo controlled trial","volume":"10","author":"Berk M","year":"2012","journal-title":"BMC Med"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.biopsych.2008.04.022","article-title":"N-acetyl cysteine for depressive symptoms in bipolar disorder-a double-blind randomized placebo-controlled trial","volume":"64","author":"Berk M","year":"2008","journal-title":"Biol Psychiatry"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ejpn.2009.07.005","article-title":"Treatment of mitochondrial disorders","volume":"14","author":"Finsterer J","year":"2010","journal-title":"Eur J Paediatr Neurol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.biopsych.2008.03.004","article-title":"N-acetyl cysteine as a glutathione precursor for schizophrenia-a double-blind, randomized, placebo-controlled trial","volume":"64","author":"Berk M","year":"2008","journal-title":"Biol Psychiatry"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0005-2728(00)00177-8","article-title":"Mitochondrial bioenergetics in aging","volume":"1459","author":"Lenaz G","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"ref27","first-page":"741","article-title":"Coenzyme Q10 improves mitochondrial respiration in patients with mitochondrial cytopathies. An in vivo study on brain and skeletal muscle by phosphorous magnetic resonance spectroscopy","volume":"43","author":"Barbiroli B","year":"1997","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"ref28","author":"Brady K","year":"1996"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1212\/WNL.42.6.1203","article-title":"31P NMR spectroscopy and ergometer exercise test as evidence for muscle oxidative performance improvement with coenzyme Q in mitochondrial myopathies","volume":"42","author":"Bendahan D","year":"1992","journal-title":"Neurology"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1176\/ajp.155.9.1207","article-title":"Markers of glutamatergic neurotransmission and oxidative stress associated with tardive dyskinesia","volume":"155","author":"Tsai G","year":"1998","journal-title":"Am J Psychiatry"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1006\/bcmd.1996.0104","article-title":"Fluorescent indicators give biased estimates of intracellular free calcium change in aggregating platelets: Implications for studies with human von willebrand factor","volume":"22","author":"Kermode JC","year":"1996","journal-title":"Blood Cells Mol Dis"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/biof.5520090222","article-title":"Coenzyme Q10 administration and its potential for treatment of neurodegenerative diseases","volume":"9","author":"Beal MF","year":"1999","journal-title":"Biofactors"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1212\/WNL.50.3.793","article-title":"Absorption, tolerability, and effects on mitochondrial activity of oral coenzyme Q10 in parkinsonian patients","volume":"50","author":"Shults CW","year":"1998","journal-title":"Neurology"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0891-5849(96)00269-9","article-title":"Neuroprotection by the metabolic antioxidant alpha-lipoic acid","volume":"22","author":"Packer L","year":"1997","journal-title":"Free Radic Biol Med"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/j.1471-4159.2007.05174.x","article-title":"Excitotoxic damage, disrupted energy metabolism, and oxidative stress in the rat brain: antioxidant and neuroprotective effects of L-carnitine","volume":"105","author":"Silva-Adaya D","year":"2008","journal-title":"J Neurochem"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.euroneuro.2005.10.005","article-title":"A double-blind, randomised, controlled clinical trial of acetyl-L-carnitine vs. amisulpride in the treatment of dysthymia","volume":"16","author":"Zanardi R","year":"2006","journal-title":"Eur Neuropsychopharmacol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"5327","DOI":"10.1021\/pr8004088","article-title":"Hypo-phosphorylation of salivary peptidome as a clue to the molecular pathogenesis of autism spectrum disorders","volume":"7","author":"Castagnola M","year":"2008","journal-title":"J Proteome Res"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/j.1399-5618.2006.00369.x","article-title":"Prospective predictors of suicide and suicide attempts in 1,556 patients with bipolar disorders followed for up to 2 years","volume":"8","author":"Marangell LB","year":"2006","journal-title":"Bipolar Disord"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.biopsych.2008.11.010","article-title":"Elevated cerebrospinal fluid lactate concentrations in patients with bipolar disorder and schizophrenia: implications for the mitochondrial dysfunction hypothesis","volume":"65","author":"Regenold WT","year":"2009","journal-title":"Biol Psychiatry"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1080\/07315724.1999.10718830","article-title":"L-carnitine improves glucose disposal in type 2 diabetic patients","volume":"18","author":"Mingrone G","year":"1999","journal-title":"J Am Coll Nutr"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.bbalip.2011.06.014","article-title":"Hiding in plain sight: uncovering a new function of vitamin A in redox signaling","volume":"1821","author":"Hoyos B","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00213-011-2175-x","article-title":"Exploring the relationship between vitamin D and basic personality traits","volume":"215","author":"Ubbenhorst A","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s002130050517","article-title":"Vitamin D3 enhances mood in healthy subjects during winter","volume":"135","author":"Lansdowne AT","year":"1998","journal-title":"Psychopharmacology (Berl)"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1056\/NEJMra070553","article-title":"Vitamin D deficiency","volume":"357","author":"Holick MF","year":"2007","journal-title":"N Engl J Med"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.yfrne.2012.07.001","article-title":"Vitamin D, effects on brain development, adult brain function and the links between low levels of vitamin D and neuropsychiatric disease","volume":"34","author":"Eyles DW","year":"2013","journal-title":"Front Neuroendocrinol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1471-244X-10-38","article-title":"Dietary intake of fish, omega-3, omega-6 polyunsaturated fatty acids and vitamin D and the prevalence of psychotic-like symptoms in a cohort of 33,000 women from the general population","volume":"10","author":"Hedelin M","year":"2010","journal-title":"BMC Psychiatry"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.1073\/pnas.81.11.3529","article-title":"31P NMR study of improvement in oxidative phosphorylation by vitamins K3 and C in a patient with a defect in electron transport at complex III in skeletal muscle","volume":"81","author":"Eleff S","year":"1984","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0165-0327(85)90077-1","article-title":"Reversal of vanadate-induced inhibition of Na-K ATPase. A possible explanation of the therapeutic effect of carbamazepine in affective illness","volume":"8","author":"Naylor GJ","year":"1985","journal-title":"J Affect Disord"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1017\/S0033291700052065","article-title":"Vanadium: a possible aetiological factor in manic depressive illness","volume":"11","author":"Naylor GJ","year":"1981","journal-title":"Psychol Med"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0304-4165(01)00235-5","article-title":"Ascorbic acid: much more than just an antioxidant","volume":"1569","author":"Arrigoni O","year":"2002","journal-title":"Biochim Biophys Acta"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/0006-291X(90)91971-T","article-title":"Antioxidant effects of ubiquinones in microsomes and mitochondria are mediated by tocopherol recycling","volume":"169","author":"Kagan V","year":"1990","journal-title":"Biochem Biophys Res Commun"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1203\/00006450-199409000-00013","article-title":"Molecular analysis of abnormal pyruvate dehydrogenase in a patient with thiamine-responsive congenital lactic acidemia","volume":"36","author":"Naito E","year":"1994","journal-title":"Pediatr Res"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.cbi.2006.04.014","article-title":"Mitochondrial function and toxicity: role of the B vitamin family on mitochondrial energy metabolism","volume":"163","author":"Depeint F","year":"2006","journal-title":"Chem Biol Interact"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1124\/jpet.107.120758","article-title":"NAD+ and vitamin B3: from metabolism to therapies","volume":"324","author":"Sauve AA","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.freeradbiomed.2003.09.012","article-title":"Effect of vitamin B6 on oxygen radicals, mitochondrial membrane potential, and lipid peroxidation in H2O2-treated U937 monocytes","volume":"36","author":"Kannan K","year":"2004","journal-title":"Free Radic Biol Med"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0306-4522(96)00430-7","article-title":"Effect of 2-cyclohexene-1-one-induced glutathione diminution on ischemia\/reperfusion-induced alterations in the physical state of brain synaptosomal membrane proteins and lipids","volume":"77","author":"Hall NC","year":"1997","journal-title":"Neuroscience"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1753-4887.1997.tb06468.x","article-title":"Nutrition and depression: the role of folate","volume":"55","author":"Alpert JE","year":"1997","journal-title":"Nutr Rev"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1192\/S0007125000193250","article-title":"Folate deficiency in depressive illness","volume":"117","author":"Reynolds EH","year":"1970","journal-title":"Br J Psychiatry"},{"issue":"(4)","key":"ref59","first-page":"CD004514","article-title":"Folic acid with or without vitamin B12 for cognition and dementia","author":"Malouf M","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0163-8343(01)00181-5","article-title":"Mood disorder with mixed features due to vitamin B(12) and folate deficiency","volume":"24","author":"Fafouti M","year":"2002","journal-title":"Gen Hosp Psychiatry"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0010-440X(97)90932-9","article-title":"An association between subcortical dementia and pernicious anemia-a psychiatric mask","volume":"38","author":"Saracaceanu E","year":"1997","journal-title":"Compr Psychiatry"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1001\/archneur.64.7.nct60005","article-title":"Randomized, double-blind, placebo-controlled trial on symptomatic effects of coenzyme Q(10) in Parkinson disease","volume":"64","author":"Storch A","year":"2007","journal-title":"Arch Neurol"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0306-9877(91)90181-W","article-title":"Subtle vitamin-B12 deficiency and psychiatry: a largely unnoticed but devastating relationship?","volume":"34","author":"Dommisse J","year":"1991","journal-title":"Med Hypotheses"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1176\/ajp.141.2.300","article-title":"A case of mania secondary to vitamin B12 deficiency","volume":"141","author":"Goggans FC","year":"1984","journal-title":"Am J Psychiatry"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.brainres.2005.05.074","article-title":"Folate, vitamin E, and acetyl-L-carnitine provide synergistic protection against oxidative stress resulting from exposure of human neuroblastoma cells to amyloid-beta","volume":"1061","author":"Dhitavat S","year":"2005","journal-title":"Brain Res"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery SA","year":"1979","journal-title":"Br J Psychiatry"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.2044-8260.1967.tb00530.x","article-title":"Development of a rating scale for primary depressive illness","volume":"6","author":"Hamilton M","year":"1967","journal-title":"Br J Soc Clin Psychol"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1601-5215.2010.00472.x","article-title":"The validity and internal structure of the Bipolar Depression Rating Scale: data from a clinical trial of N-acetylcysteine as adjunctive therapy in bipolar disorder","volume":"22","author":"Berk M","year":"2010","journal-title":"Acta Neuropsychiatrica"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A rating scale for mania: reliability, validity and sensitivity","volume":"133","author":"Young RC","year":"1978","journal-title":"Br J Psychiatry"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0165-1781(97)00123-6","article-title":"Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI-BP","volume":"73","author":"Spearing MK","year":"1997","journal-title":"Psychiatry Res"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1600-0447.2000.tb10933.x","article-title":"Development, reliability and acceptability of a new version of the DSM-IV Social and Occupational Functioning Assessment Scale (SOFAS) to assess routine social functioning","volume":"101","author":"Morosini PL","year":"2000","journal-title":"Acta Psychiatr Scand"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1001\/archpsyc.1987.01800180050009","article-title":"The Longitudinal Interval Follow-up Evaluation. A comprehensive method for assessing outcome in prospective longitudinal studies","volume":"44","author":"Keller MB","year":"1987","journal-title":"Arch Gen Psychiatry"},{"key":"ref73","first-page":"321","article-title":"Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure","volume":"29","author":"Endicott J","year":"1993","journal-title":"Psychopharmacol Bull"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1192\/bjp.183.3.228","article-title":"Standardised Assessment of Personality - Abbreviated Scale (SAPAS): preliminary validation of a brief screen for personality disorder","volume":"183","author":"Moran P","year":"2003","journal-title":"Br J Psychiatry"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"909","DOI":"10.4088\/JCP.09m05741yel","article-title":"Qualitative methods in early-phase drug trials: broadening the scope of data and methods from an RCT of N-acetylcysteine in schizophrenia","volume":"72","author":"Berk M","year":"2011","journal-title":"J Clin Psychiatry"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.neubiorev.2010.10.001","article-title":"Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors","volume":"35","author":"Berk M","year":"2011","journal-title":"Neurosci Biobehav Rev"}],"container-title":["Revista Brasileira de Psiquiatria"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/rbp\/v37n1\/1516-4446-rbp-1516-4446-2013-1341.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T16:13:24Z","timestamp":1654532004000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S1516-44462015000100003&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,7]]},"references-count":76,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,3]]}},"alternative-id":["S1516-44462015000100003"],"URL":"https:\/\/doi.org\/10.1590\/1516-4446-2013-1341","relation":{},"ISSN":["1809-452X","1516-4446"],"issn-type":[{"value":"1809-452X","type":"electronic"},{"value":"1516-4446","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10,7]]}}}